Compounds for the treatment of dyslipidemia and other lipid disorders
    3.
    发明授权
    Compounds for the treatment of dyslipidemia and other lipid disorders 失效
    用于治疗血脂异常和其他脂质疾病的化合物

    公开(公告)号:US07629372B2

    公开(公告)日:2009-12-08

    申请号:US11662808

    申请日:2005-09-12

    IPC分类号: A61K31/423 C07D261/20

    CPC分类号: C07D261/20 C07D413/12

    摘要: A class of compounds having Formula I and pharmaceutically acceptable salts thereof are useful as therapeutic compounds, particularly in the treatment of hyperlipidemia, hypercholesterolemia, dyslipidemia, and other lipid disorders, and in delaying the onset of or reducing the risk of developing conditions and sequelae that are associated with these diseases, such as atherosclerosis.

    摘要翻译: 一类具有式I的化合物及其药学上可接受的盐可用作治疗性化合物,特别是用于治疗高脂血症,高胆固醇血症,血脂异常和其它脂质疾病,以及延迟发展或降低发展疾病和后遗症的风险, 与这些疾病有关,如动脉粥样硬化。

    Antidiabetic Oxazolidinediones and Thiazolidinediones
    6.
    发明申请
    Antidiabetic Oxazolidinediones and Thiazolidinediones 审中-公开
    抗糖尿病恶唑烷二酮类和噻唑烷二酮类

    公开(公告)号:US20090069385A1

    公开(公告)日:2009-03-12

    申请号:US11988791

    申请日:2006-07-14

    IPC分类号: A61K31/4439 C07D417/12

    CPC分类号: C07D417/14

    摘要: Pyridinyloxyphenyl and pyridinyloxybenzyl oxazolidine-2,4-diones and thiazolidine-2,4-diones are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.

    摘要翻译: 吡啶氧基苯基和吡啶氧基苄基恶唑烷-2,4-二酮和噻唑烷-2,4-二酮是PPARγ的激动剂或部分激动剂,可用于治疗和控制II型糖尿病症状的高血糖,以及血脂异常,高脂血症 ,高胆固醇血症,高甘油三酯血症和通常与2型糖尿病相关的肥胖症。

    PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
    7.
    发明授权
    PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders 失效
    用于治疗血脂异常和其他脂质障碍的PPARα选择性化合物

    公开(公告)号:US07524882B2

    公开(公告)日:2009-04-28

    申请号:US10522259

    申请日:2003-07-25

    申请人: Guo Q. Shi Yong Zhang

    发明人: Guo Q. Shi Yong Zhang

    摘要: A class of benzodihydrofuran compounds having the structure of formula (I) below and pharmaceutically acceptable salts thereof are useful as therapeutic compounds, particularly in the treatment of hyperlipidemia, hypercholesterolemia, dyslipidemia, and other lipid disorders, and in delaying the onset of or reducing the risk of conditions and sequelae that are associated with these diseases, such as atherosclerosis.

    摘要翻译: 一类具有下式(I)结构的苯并二氢呋喃化合物及其药学上可接受的盐可用作治疗性化合物,特别是用于治疗高脂血症,高胆固醇血症,血脂异常和其它脂质疾病,并且延迟开始或减少 与这些疾病相关的病症和后遗症的风险,如动脉粥样硬化。